We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAIL icon
12626
FreightCar America
RAIL
$270M
$112K ﹤0.01%
24,644
+9,497
+63% +$50.1K
AIOT
12627
PowerFleet Inc
AIOT
$548M
$112K ﹤0.01%
16,729
-42,004
-72% -$291K
QCLS
12628
Q/C Technologies Inc
QCLS
$21.6M
$112K ﹤0.01%
5
-2
-29% -$35.9K
BLNE
12629
PUT
Beeline Holdings
BLNE
$32.8M
$112K ﹤0.01%
+215
New +$142K
ORGS
12630
DELISTED
Orgenesis Inc. Common Stock
ORGS
$112K ﹤0.01%
2,270
-545
-19% -$27.4K
EIGR
12631
PUT
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$112K ﹤0.01%
557
+10
+2% +$2.38K
GTPAW
12632
DELISTED
Gores Technology Partners, Inc. Warrant
GTPAW
$112K ﹤0.01%
100,000
GSS
12633
CALL
DELISTED
Golden Star Resources Ltd.
GSS
$112K ﹤0.01%
47,200
-38,900
-45% -$93.5K
PEI
12634
PUT
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$112K ﹤0.01%
3,860
-2,613
-40% -$80K
SRTA
12635
Strata Critical Medical Inc
SRTA
$480M
$111K ﹤0.01%
10,692
-175,365
-94% -$1.53M
DARE icon
12636
Dare Bioscience
DARE
$19.2M
$111K ﹤0.01%
+5,551
New +$109K
INDP icon
12637
Indaptus Therapeutics
INDP
$175M
$111K ﹤0.01%
508
+398
+362% +$115K
OSW icon
12638
PUT
OneSpaWorld
OSW
$2.68B
$111K ﹤0.01%
11,100
-46,500
-81% -$458K
GFX.U
12639
DELISTED
Golden Falcon Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
GFX.U
$111K ﹤0.01%
11,059
-603,351
-98% -$6.07M
ANAC.WS
12640
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$111K ﹤0.01%
150,098
-67,074
-31% -$57.5K
MTCR
12641
DELISTED
Metacrine, Inc. Common Stock
MTCR
$111K ﹤0.01%
32,429
+19,719
+155% +$61.5K
PAQCW
12642
DELISTED
Provident Acquisition Corp. Warrant
PAQCW
$111K ﹤0.01%
+185,438
New +$136K
WARR.WS
12643
DELISTED
Warrior Technologies Acquisition Company Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
WARR.WS
$111K ﹤0.01%
+203,149
New +$137K
NPTN
12644
DELISTED
NEOPHOTONICS CORP
NPTN
$111K ﹤0.01%
12,791
-39,810
-76% -$363K
BTAQU
12645
DELISTED
Burgundy Technology Acquisition Corporation Unit
BTAQU
$111K ﹤0.01%
10,832
+115
+1% +$1.18K
AYTU icon
12646
CALL
AYTU BioPharma
AYTU
$24.1M
$110K ﹤0.01%
1,904
+64
+3% +$4.8K
BVN icon
12647
PUT
Compañía de Minas Buenaventura
BVN
$7.74B
$110K ﹤0.01%
16,300
-53,000
-76% -$409K
ELMD icon
12648
CALL
Electromed
ELMD
$344M
$110K ﹤0.01%
10,200
-1,100
-10% -$13.2K
EVC icon
12649
PUT
Entravision Communication
EVC
$1.02B
$110K ﹤0.01%
15,500
+300
+2% +$2.02K
FLUX icon
12650
PUT
Flux Power
FLUX
$11.6M
$110K ﹤0.01%
+21,700
New +$183K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.